Chat with us, powered by LiveChat

Personalized Healthcare Market, by Application (Clinical Research, Health Informatics, Biomarker Identification, and Companion Diagnostics), Therapeutic Area (Cardiology, Oncology, Neurology, Antiviral, Psychiatry, and Others), End User (Hospitals, Contract Research Organizations, Bio and Health Informatics Companies, Academic Research, Clinical Care, Research Laboratories, and Others), and Region (North America, Europe, Asia Pacific, Middle East and Africa, South America) — Industry Trends and Forecast to 2030

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

The Global Personalized Healthcare Market is expected to value USD XX.XX million in 2021 and is expected to grow at a CAGR of XX.X% during the forecast period. Personalized healthcare is a process where patient’s unique characteristics are taken into account such as clinical history and risk factors and to provide them with personalizes treatment and care.

The prevalence of innovative treatments with advanced technology for the treatment of various diseases are driving the personalized healthcare market.

Also, fewer reimbursement policies available in underdeveloped countries and lack of knowledge over the applications usage are restraining the personalized healthcare market.

Some advantages of personalized healthcare are that, it can be highly used to detect and diagnose diseases in a specific manner which allows treatment to be specific and effective by improving the prognosis. And these factors are creating opportunities for the service providers of personalized healthcare.

However, there are some factors involved in the field of personalized healthcare market such as ethical concerns relating to incidental diseases discovery are challenging the market growth.

Impact of COVID-19 on Global Personalized Healthcare Market

The emergence of Covid-19 has shown disrupted changes in every organization but it has shown positive impact on healthcare sectors due to increasing health disorders.

During the pandemic situation, patients who has faced coronavirus infections are at higher risk with cardiovascular and lungs disorders which have increased the personalized healthcare market growth.

Also, the rapid spread of infections during the pandemic has increased the number of patients to adopt the advantages of personalized healthcare service. And hence anticipated to uplift its revenue structure during the coming projected period.

TABLE 1: GLOBAL PERSONALIZED HEALTHCARE MARKET OVERALL SNAPSHOT

TABLE 1: GLOBAL PERSONALIZED HEALTHCARE MARKET OVERALL SNAPSHOT

Market Segmentation

The global personalized healthcare market report has been segmented by application, therapeutic area, end user, and region.

FIGURE 2: GLOBAL PERSONALIZED HEALTHCARE MARKET SEGMENTATION

FIGURE 2: GLOBAL PERSONALIZED HEALTHCARE MARKET SEGMENTATION

Global Personalized Healthcare Market, by Application

Based on application, the global personalized healthcare market is segmented into clinical research, health informatics, biomarker identification, and companion diagnostics. Among these, companion diagnostics holds the highest market share in 2021 and anticipated to remain highest during the coming forecast period.

Factors attributing the growth of companion diagnostics segment is due to its advantages such as it confers multiple benefits to drug development.

Also, they can identify patients more likely to respond to a targeted drug, which can deliver right drugs to right patient at right time. And hence, these factors are driving the market growth for companion diagnostics segment.

Global Personalized Healthcare Market, by Therapeutic Area

Based on therapeutic area, the global personalized healthcare market is bifurcated into cardiology, oncology, neurology, antiviral, psychiatry, and others. Oncology segment captures the largest market share in 2021 and anticipated to remain largest during the coming forecast period.

Factors attributing the growth of oncology therapy is because of increasing cancers due to various changes in food habits and lifestyles.

Hence, with technological advancement for the treatment of various cancers increasing in western countries are driving the growth of oncology segment in personalized healthcare market.

Global Personalized Healthcare Market, by End User

Based on end user, the global personalized healthcare market is segmented into hospitals, contract research organizations (CROs), bio and health informatics companies, academic institutes, clinical care, research laboratories, others (service providers, venture capitalists, partners, etc.).

Among these, hospitals segment is the dominating the global personalized healthcare market in 2021 and expected to remain largest during the projected period due to increasing health disorders such as cardiovascular, cancer, and others.

Additionally, advanced technologies with innovative equipment mostly serves quality treatments in hospitals. And hence, increasing the demands for hospitals segment.

Global Personalized Healthcare Market, by Region

Based on region, the market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South America. Among these, North America is the dominating market for personalized healthcare in 2021 and expected to remain dominant during the forecast period.

Factors uplifting the growth of North American market is because of increasing investments for the development of healthcare sectors along with rising R&D sectors are boosting the global personalized healthcare market growth.

TABLE 2: GLOBAL PERSONALIZED HEALTHCARE MARKET OVERVIEW

TABLE 2: GLOBAL PERSONALIZED HEALTHCARE MARKET OVERVIEW

FIGURE 3: GLOBAL PERSONALIZED HEALTHCARE MARKET (USD MILLION), 2021–2030

FIGURE 3: GLOBAL PERSONALIZED HEALTHCARE MARKET (USD MILLION), 2021–2030

Recent Developments in the Global Personalized Healthcare Market

  • August 2021 – HealthTrust launches personalized medicine program Coriell Life Sciences’Corigen® medication safety program, to improve healthcare delivery for public sector employees. The program applies science of pharmacogenomics to improve how drugs to be prescribed and measure each person’s respond for medications.
  • May 2018 – Advanced diagnostic laboratory test (ADLT) received approval for FoundationOne CDx™ announced by Foundation Medicine, Inc., under the Protecting Access to Medicare Act of 2014 (PAMA).
  • October 2018 – Qiagen N.V. announced novel RNA-seq for next generation sequencing in library presentation solutions. QIAseq FastSelect RNA Removal Kit which provides a completely unique solution for scientists to focus on RNA types is a key element of this portfolio.
  • January 2018 – Foundation Medicine and European Organization for Research and Treatment for Cancer has announced their collaboration for promoting Foundation’s comprehensive genomic profiling in personalized medicine sector.

What Does This Report Provide?

This report provides a detailed understanding of the global personalized healthcare market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market. The major market drivers, challenges, and opportunities for the global personalized healthcare market have been covered in the report. This report further includes the market shares of the leading companies operating in the global market, along with their production capacities and the growth strategies adopted by them.

Market Segmentation:

By Application:

  • Clinical Research
  • Health Informatics
  • Biomarker Identification
  • Companion Diagnostics

By Therapeutic Area:

  • Cardiology
  • Oncology
  • Neurology
  • Antiviral
  • Psychiatry
  • Others

By End User:

  • Hospitals
  • Contract Research Organizations (CRO)
  • Bio and Health Informatics Companies
  • Academic Institutes
  • Clinical Care
  • Research Laboratories
  • Others (Service providers, venture capitalists, partners, etc.)

By Region:

North America Personalized Healthcare Market

  • North America, by Country
    • U.S.
    • Canada
    • Mexico
  • North America, by Application
  • North America, by Therapeutic Area
  • North America, by End User

Europe Personalized Healthcare Market

  • Europe, by Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • The Rest of Europe 
  • Europe, by Application
  • Europe, by Therapeutic Area
  • Europe, by End User

Asia Pacific Personalized Healthcare Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • The Rest of Asia Pacific 
  • Asia Pacific, by Application
  • Asia Pacific, by Therapeutic Area
  • Asia Pacific, by End User

Middle East and Africa Personalized Healthcare Market

  • Middle East and Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • The Rest of Middle East and Africa
  • Middle East and Africa, by Application
  • Middle East and Africa, by Therapeutic Area
  • Middle East and Africa, by End User

South America Personalized Healthcare Market

  • South America, by Country 
    • Brazil
    • Argentina
    • The Rest of South America
  • South America, by Application
  • South America, by Therapeutic Area
  • South America, by End User

Major Companies: In this report, the major companies studied are: GE Healthcare, Illumina Inc., Cepheid, Abbot Incorporated, Exagen Diagnostics Inc., Biogen, Genelex Corp., Asuragen Incorporated, Dako A/S, DNA Direct, Agendia N.V., and Qiagen Inc.

Objectives of this Report:

  • To estimate the market size for the personalized healthcare market on a regional and global basis.
  • To identify major segments in the personalized healthcare market and evaluate their market shares and demand.
  • To provide a competitive scenario for the personalized healthcare market with major developments observed by the key companies in the historic years.
  • To evaluate key factors governing the dynamics of personalized healthcare market with their potential growth during the forecast period.
  • To evaluate the leading company-wise pricing analysis for the mentioned applications.

 Key Questioned Answered in the Study:

  • What are major growth drivers and market trends that impacting on personalized healthcare market?
  • What the market size both in terms of value and volume for global personalized healthcare market?
  • Who are leading market players and who are the new market players that operate in the global personalized healthcare market with an estimated market share?
  • What are the future investment pockets and opportunity in the global personalized healthcare market?
  • Major list of customers and potential futuristic customer list along with an estimated buying volume
  • Impact of COVID-19 on global personalized healthcare market

Customization:

This study is customized to meet your specific requirements:

  • By sub-segment
  • By client-specific country, type, and application market analysis
  • Pricing analysis along with the potential list of customers
  • Product-specific competitive analysis

For more information, contact: [email protected]

Report Cover Image
Report Code :
HC2288519
Report Status :
Published
Report Format :
PDF
Share:
PURCHASE OPTIONS


 Buy Now
OUR CLIENTS
  • Quince Market Insights Syndicate Research
WHY QMI?

Detailed scope covering all the major segments in the market

In line data validations to ensure data precision

Market recommendations supporting decision making processes

Round the clock analyst support to resolve your queries

Up to 15% additional free customization to meet your specific requirements